Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Picard

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Transplantation|March 11, 2011
CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipientsNicolas Picard, Koukeb Rouguieg-Malki, Nassim Kamar, et al.
Environmental Monitoring and Assessment|April 9, 2009
Permanent sample plots for natural tropical forests: a rationale with special emphasis on Central AfricaNicolas Picard, Steen Magnussen, Ludovic Ngok Banak, et al.
Pharmacogenetics and Genomics|April 1, 2014
Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patientsJean-Baptiste Woillard, Nicolas Picard, Antoine Thierry, et al.
Journal of Separation Science|July 2, 2009
General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolismNicolas Picard, Dorra Dridi, François-Ludovic Sauvage, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 21, 2009
Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomesKoukeb Rouguieg, Nicolas Picard, François-Ludovic Sauvage, et al.
Frontiers in Endocrinology|July 25, 2022
Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?Quentin Faucher, Manon Jardou, Clarisse Brossier, et al.
Pharmacogenetics and Genomics|April 13, 2007
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patientsNassim Djebli, Nicolas Picard, Jean-Philippe Rérolle, et al.
British Journal of Clinical Pharmacology|December 15, 2006
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?Marie-Laure Laroche, Jean-Pierre Charmes, Yves Nouaille, et al.
Frontiers in Cellular and Infection Microbiology|March 13, 2024
Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenanceManon Jardou, Clarisse Brossier, Pierre Marquet, et al.
Analytical Biochemistry|May 15, 2012
Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometryAnne-Laure Gagez, Koukeb Rouguieg-Malki, François-Ludovic Sauvage, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Transplantation|March 11, 2011
CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipientsNicolas Picard, Koukeb Rouguieg-Malki, Nassim Kamar, et al.
Environmental Monitoring and Assessment|April 9, 2009
Permanent sample plots for natural tropical forests: a rationale with special emphasis on Central AfricaNicolas Picard, Steen Magnussen, Ludovic Ngok Banak, et al.
Pharmacogenetics and Genomics|April 1, 2014
Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patientsJean-Baptiste Woillard, Nicolas Picard, Antoine Thierry, et al.
Journal of Separation Science|July 2, 2009
General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolismNicolas Picard, Dorra Dridi, François-Ludovic Sauvage, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 21, 2009
Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomesKoukeb Rouguieg, Nicolas Picard, François-Ludovic Sauvage, et al.
Frontiers in Endocrinology|July 25, 2022
Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?Quentin Faucher, Manon Jardou, Clarisse Brossier, et al.
Pharmacogenetics and Genomics|April 13, 2007
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patientsNassim Djebli, Nicolas Picard, Jean-Philippe Rérolle, et al.
British Journal of Clinical Pharmacology|December 15, 2006
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?Marie-Laure Laroche, Jean-Pierre Charmes, Yves Nouaille, et al.
Frontiers in Cellular and Infection Microbiology|March 13, 2024
Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenanceManon Jardou, Clarisse Brossier, Pierre Marquet, et al.
Analytical Biochemistry|May 15, 2012
Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometryAnne-Laure Gagez, Koukeb Rouguieg-Malki, François-Ludovic Sauvage, et al.
Pageof 16